New ANDA Cases

Fall 2012

GENERICally Speaking

Case Name

Date Filed

Judge

Drug

Patent
No(s).

Pfizer Inc. v. Roxane Labs., Inc., 12-0593 (S.D. Ohio)

July 3, 2012

Hon. Edmund A. Sargus

Pristiq®(desvenlafaxine)

6,673,838

Endo Pharma. Inc. v. TWI Pharma., Inc., 12-0848 (D. Del.)

July 5, 2012

Hon. Gregory M. Sleet

Lidoderm®Patch (lidocaine)

5,741,510

6,096,334

5,827,529

Cubist Pharma., Inc. v. Hospira, Inc., 12-0859 (D. Del.)

July 9, 2012

Hon. Gregory M. Sleet

Cubicin®(daptomycin for injection)

8,129,342

Shionogi, Inc. v. Nostrum Labs., Inc., 12-4402 (D.N.J.)

July 13, 2012

Hon. Robert B. Kugler

Fortamet®(metformin hydrochloride extended-release tablets)

6,099,859

6,866,866

Novartis Pharma. Corp. v. Sun Pharma. Indus., Inc., 12-4393 (D.N.J.)

July 14, 2012

Hon. Susan D. Wigenton

Zometa®(zoledronic acid)

Reclast®(zoledronic acid)

7,932,241

Alcon Pharma. Ltd. v. Apotex Inc., 12-0960 (D. Del.)

July 20, 2012

Hon. Sue L. Robinson

Vigamox®(moxifloxacin hydrochloride ophthalmic solution)

6,716,830

7,671,070

 

Novartis Pharma. Corp. v. Lupin Ltd., 12-4552 (D.N.J.)

July 20, 2012

Hon. William J. Martini

Diovan HCT®(valsartan / hydrochlorothiazide tablets)

6,294,197

Celgene Corp. v. Natco Pharma. Ltd., 12-4571 (D.N.J.)

July 20, 2012

Hon. Susan D. Wigenton

Revlimid®(lenalidomide capsules)

5,635,517

6,281,230

7,189,740

7,968,569

7,977,357

8,193,219

Purdue Pharma L.P. v. Actavis Elizabeth LLC, 12-5615 (S.D.N.Y.)

July 20, 2012

Hon. Sidney H. Stein

OxyContin®(oxycodone hydrochloride extended-release tablets)

8,114,383

Alcon Pharma. Ltd. v. Lupin Ltd., 12-0973 (D. Del.)

July 24, 2012

Hon. Sue L. Robinson

Moxeza®(moxifloxacin hydrochloride ophthalmic solution)

6,716,830

7,671,070

 

Sunovion Pharma. Inc. v. Watson Pharma., Inc., 12-0993 (D. Del.)

July 27, 2012

Hon. Leonard P. Stark

Xopenex HFA®(levalbuterol tartrate inhalation aerosol)

7,256,310

Southern Research Institute v. Abon Pharma LLC, 12-4709 (D.N.J.)

July 27, 2012

Hon. William J. Martini

Clolar®(clofarabine injection)

5,661,136

Meda Pharma. Inc. v. Cadila Healthcare Ltd., 12-4719 (D.N.J.)

July 27, 2012

Hon. Michael A. Shipp

Astepro®(azelastine 0.15 % nasal spray)

8,071,073

Galderma Labs., L.P. v. Watson Pharma., Inc., 12-2563 (N.D. Tex.)

July 27, 2012

Hon. Ed Kinkeade

Epiduo®(adapalene / benzoyl peroxide gel)

8,071,644

8,080,537

8,129,362

Millenium Pharma. Inc. v. Sandoz Inc., 12-1011 (D. Del.)

Aug. 2, 2012

Hon. Gregory M. Sleet

Velcade®(bortezomib injection)

6,713,446

6,958,319

Astrazeneca Pharma. LP v. Amneal Pharma., LLC, 12-4841 (D.N.J.)

Aug. 2, 2012

Hon. Joel A Pisano

Seroquel XR®(quetiapine fumarate extended-release tablets)

5,948,437

Nycomed Gmbh v. Apotex Inc., 12-1073 (S.D. Ind.)

Aug. 2, 2012

Hon. Tanya W. Pratt

Omnaris®(ciclesonide nasal spray)

6,767,901

6,939,559

7,235,247

Cumberland Pharma. Inc. v. Perrigo Co., 12-6327 (N.D. Ill.)

Aug. 9, 2012

Hon. Ruben Castillo

Acetadote®(acetylcysteine intravenous)

8,148,356

Janssen Pharma., Inc. v. Glenmark Generics Ltd., 12-5009 (D.N.J.)

Aug. 9, 2012

Hon. Stanley R. Chessler

Ortho Tri-Cyclen®LO (norgestimate / ethinyl estradiol)

6,214,815

Luitpold Pharma., Inc. v. Amneal Pharma., LLC, 12-5064 (D.N.J.)

Aug. 10, 2012

Hon. Joel A. Pisano

Sprix®(ketorolac tromethamine nasal spray)

6,333,044

Santarus, Inc. v. Dr. Reddy’s Labs. Inc., 12-5202 (D.N.J.)

Aug. 15, 2012

Hon. Peter G. Sheridan

Zegerid®(omeprazole / sodium bicarbonate capsules)

6,699,885

6,489,346

6,645,988

7,399,772

Gilead Sciences, Inc. v. Lupin Ltd., 12-6293 (S.D.N.Y.)

Aug. 16, 2012

Hon. Richard J. Sullivan

Emtriva®(emtricitabine capsules)

6,642,245

6,703,396

Merck Sharp & Dohme Corp. v. Watson Labs., Inc., 12-5228 (D.N.J.)

Aug. 20, 2012

Hon. Freda L. Wolfson

Propecia®(finasteride tablets)

5,571,817

5,547,957

Gilead Sciences, Inc. v. Cipla Ltd., 12-6350 (S.D.N.Y.)

Aug. 20, 2012

Hon. Richard J. Sullivan

Emtriva®(emtricitabine capsules)

6,642,245

6,703,396

Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. v. Actavis South Atlantic LLC, 12-1061 (D. Del.)

Aug. 21, 2012

Hon. Leonard P. Stark

Oleptro®(trazodone hydrochloride extended-release tablets)

8,133,893

ViiV Healthcare Co. v. Mylan Inc., 12-1065 (D. Del.)

Aug. 22, 2012

Hon. Richard G. Andrews

Lexiva®(fosamprenavir calcium tablets)

6,436,989

Purdue Pharma. Products L.P. v. Actavis Elizabeth LLC, 12-5311 (D.N.J.)

Aug. 23, 2012

Hon. Jose L. Linares

Intermezzo®(zolpidem tartrate tablets)

7,682,628

Janssen Products, L.P. v. Lupin Ltd., 12-5358 (D.N.J.)

Aug. 24, 2012

Hon. William H. Walls

Prezista®(darunavir tablets)

RE43,596

Purdue Pharma. Products L.P. v. Watson Pharma., Inc., 12-5390 (D.N.J.)

Aug. 27, 2012

Hon. Jose L. Linares

Intermezzo®(zolpidem tartrate tablets)

7,682,628

Merck & Co., Inc. v. Sun Pharma. Indus., Ltd., 12-5374 (D.N.J.)

Aug. 27, 2012

Hon. Freda L. Wolfson

Ganirelix Acetate Injection

5,757,082

6,653,286

Mallinckrodt, LLC v. Apotex Inc., 12-1087

Aug. 30, 2012

Hon. Mary Pat Thynge

Pennsaid®(diclofenac sodium topical solution)

8,217,078

AbbVie, Inc. v. Amneal Pharma., LLC, 12-1088 (D. Del.)

Aug. 30, 2012

Hon. Sue L. Robinson

Niaspan®(niacin extended-release tablets)

6,080,428

GlaxoSmithKline LLC v. Apotex Inc., 12-1090 (D. Del.)

Aug. 31, 2012

Hon. Richard G. Andrews

Avodart®(dutasteride capsules)

5,565,467

Medicis Pharma. Corp. v. Actavis Mid Atlantic LLC, 12-1091 (D. Del.)

Aug. 31, 2012

Hon. Leonard P. Stark

Zyclara®(imiquimod) Cream (3.75%)

8,236,816

Teva Branded Pharma. Products R&D, Inc. v. Perrigo Pharma. Co., 12-1101 (D. Del.)

Sept. 5, 2012

Hon. Gregory M. Sleet

ProAir®HFA (albuterol sulfate) Inhalation Aerosol

7,105,152

7,566,445

Novartis Pharma. Corp. v. Apotex Inc., 12-5574 (D.N.J.)

Sept. 6, 2012

Hon. Jose L. Linares

Lotrel®(amlodipine / benazepril hydrochloride capsules)

6,162,802

Salix Pharma., Inc. v. Lupin Ltd., 12-1104 (D. Del.)

Sept. 7, 2012

Hon. Gregory M. Sleet

Apriso®(mesalamine extended-release capsules)

6,551,620

Salix Pharma., Inc. v. Lupin Ltd., 12-2708 (D. Md.)

Sept. 10, 2012

Hon. William D. Quarles, Jr.

Apriso®(mesalamine extended-release capsules)

6,551,620

Otsuka Pharma. Co., Ltd. v. Apotex Corp., 12-5645 (D.N.J.)

Sept. 10, 2012

Hon. Mary L. Cooper

Abilify®(aripiprazole oral solution)

6,977,257

5,006,528

Upsher-Smith Labs., Inc. v. Auxilium Pharma., Inc., 12-5648 (D.N.J.)

Sept. 10, 2012

Hon. Jose L. Linares

Testim®1% (testosterone gel)

7,608,605

7,608,606

7,608,607

7,608,608

7,608,609

7,608,610

7,935,690

8,063,029

Purdue Pharma. Products L.P. v. Novel Labs., Inc., 12-5650 (D.N.J.)

Sept. 10, 2012

Hon. Jose L. Linares

Intermezzo®(zolpidem tartrate tablets)

7,682,628

Braintree Labs., Inc. v. Cypress Pharma., Inc., 12-6851 (S.D.N.Y.)

Sept. 11, 2012

Hon. Alison J. Nathan

Suprep®(sodium sulfate / potassium sulfate / magnesium sulfate oral solution)

6,946,149

Avanir Pharma., Inc. v. Actavis South Atlantic, LLC, 12-1122 (D. Del.)

Sept. 12, 2012

Hon. Leonard P. Stark

Nuedexta®(dextromethorphan hydrobromide / quinidine sulfate capsules)

8,227,484

Avanir Pharma., Inc. v. Par Pharma., Inc., 12-1123 (D. Del.)

Sept. 12, 2012

Hon. Leonard P. Stark

Nuedexta®(dextromethorphan hydrobromide / quinidine sulfate capsules)

8,227,484

Avanir Pharma., Inc. v. Watson Pharma., Inc., 12-1124 (D. Del.)

Sept. 12, 2012

Hon. Leonard P. Stark

Nuedexta®(dextromethorphan hydrobromide / quinidine sulfate capsules)

8,227,484

Avanir Pharma., Inc. v. Wockhardt Ltd., 12-1125 (D. Del.)

Sept. 12, 2012

Hon. Leonard P. Stark

Nuedexta®(dextromethorphan hydrobromide / quinidine sulfate capsules)

8,227,484

Actelion Pharma. Ltd. v. Apotex Inc., 12-5743 (D.N.J.)

Sept. 14, 2012

Hon. Noel L. Hillman

Tracleer®(bosentan tablets)

5,292,740

Otsuka Pharma. Co., Ltd. v. Silarx Pharma., Inc., 12-5809 (D.N.J.)

Sept. 14, 2012

Hon. Mary L. Cooper

Abilify®(aripiprazole oral solution)

6,977,257

Cubist Pharma., Inc. v. Hospira, Inc., 12-1142 (D. Del.)

Sept. 17, 2012

Hon. Gregory M. Sleet

Cubicin®(daptomycin for injection)

6,468,967

6,852,689

RE39,071

8,058,238

8,129,342

Merck Sharp & Dohme Corp. v. Sandoz Inc., 12-6077 (D.N.J.)

Sept. 27, 2012

Hon. Jose L. Linares

Zetia®(ezetimibe tablets)

RE42,461

5,846,966

7,030,106

7,612,058


Back to Top